original ) (raw )AN IN-VITRO STUDY OF TIGECYCLINE SUSCEPTIBILITY AMONG MULTIDRUG RESISTANT BACTERIA IN A TERTIARY CARE HOSPITAL
Scholar Science Journals
View PDFchevron_right
Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India
Prashant Gupta
Journal of clinical and diagnostic research : JCDR, 2017
View PDFchevron_right
Susceptibility to Tigecycline of Multiresistant Bacteria at Ibn Rochd University Hospital-Casablanca
assiya el kettani
2019
View PDFchevron_right
Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010
Ming-hsun Lee
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
Tigecycline susceptibility report from an Indian tertiary care hospital
Bijayini Behera
View PDFchevron_right
Agreement Assessment of Tigecycline Susceptibilities Determined by the Disk Diffusion and Broth Microdilution Methods among Commonly Encountered Resistant Bacterial Isolates: Results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) Study, 2008 to 2010
Po-ren Hsueh , Ming-hsun Lee
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Tigecycline susceptibility among multi-drug resistant bacteria: A 7-year retrospective study
Kenza El Bazi
GSC Advanced Research and Reviews
View PDFchevron_right
Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans
Aleksandra Smitran
Acta Microbiologica et Immunologica Hungarica, 2020
View PDFchevron_right
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
Theodoros Kelesidis
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right
Tigecycline in vitro activity against commonly encountered multidrug-resistant Gram-negative pathogens in a Middle Eastern country
Georges Ibrahim
Diagnostic Microbiology and Infectious Disease, 2008
View PDFchevron_right
Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany
Karsten Becker
European Journal of Clinical Microbiology & Infectious Diseases, 2011
View PDFchevron_right
In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline
martha mushi
Journal of Antimicrobial Chemotherapy, 2012
View PDFchevron_right
In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp
Alper Ergin
The new microbiologica, 2008
View PDFchevron_right
In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital
Nasser Kaplan
Journal of Infection and Public Health, 2021
View PDFchevron_right
Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries
Abdul Sattar
Diagnostic Microbiology and Infectious Disease, 2006
View PDFchevron_right
In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia
Mahmoud Shorman , Ghulam Dhabaan
Journal of Chemotherapy, 2012
View PDFchevron_right
Emergence of Tigecycline Resistant Acinetobacter baumannii from an Intensive Care Unit (ICU) in Tehran
A. Salmanian
Jundishapur Journal of Microbiology, 2013
View PDFchevron_right
Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage
Yen-hsu Chen
Journal of Microbiology, Immunology and Infection, 2011
View PDFchevron_right
In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa
Cornelis Clay
BMC Research Notes, 2012
View PDFchevron_right
In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals
Efthymia Giannitsioti
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative Pathogens
O. Zarkotou
Journal of Clinical Microbiology, 2012
View PDFchevron_right
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
Miguel Sanchez
2000
View PDFchevron_right
Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 2004 and 2009 as Part of the Tigecycline Evaluation and Surveillance Trial
Xavier Bertrand
Clinical Therapeutics, 2012
View PDFchevron_right